Glucosio Monico (Glucose Monohydrate)

Glucosio Monico is indicated for several clinical situations where intravenous glucose is required. It is commonly employed in the following contexts:

• Treatment of acute hypoglycemia to quickly raise blood glucose concentrations.
• Provision of an energy substrate in parenteral nutrition regimens.
• Fluid and electrolyte replacement when combined with appropriate electrolytes.
• Support during surgical procedures or critical care when oral intake is not possible.
• Management of metabolic disorders that impair endogenous glucose production.

Glucosio Monico may be associated with a range of adverse reactions, most of which are related to its osmolarity and rapid infusion.

Common

• Hyperglycemia due to excess glucose administration.
• Local irritation or pain at the injection site.
• Electrolyte imbalances, particularly hyponatremia or hypernatremia when mixed with saline.
• Fluid overload in patients with compromised cardiac or renal function.
• Nausea or vomiting following rapid infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reactions, including rash, urticaria, or anaphylaxis.
• Metabolic acidosis in patients with impaired lactate clearance.
• Pulmonary edema secondary to fluid overload.
• Thrombophlebitis from prolonged peripheral infusion.

When prescribing Glucosio Monico, clinicians should consider several safety factors to minimize risk. Important precautions include:

• Assess baseline blood glucose and monitor levels frequently during infusion.
• Adjust infusion rates in patients with renal or cardiac insufficiency to avoid fluid overload.
• Use central venous access for high‑volume or high‑concentration solutions.
• Review electrolyte status, especially sodium and potassium, before and during therapy.
• Avoid rapid bolus administration unless clinically indicated.
• Consider alternative carbohydrate sources in patients with known glucose intolerance or allergy to formulation components.
• Document any adverse reactions and adjust therapy accordingly.

Glucosio Monico can interact with other medications or clinical conditions, influencing its safety and efficacy. Interaction considerations are:

Avoid

• Concurrent use of insulin or other hypoglycemic agents without close glucose monitoring, as this may precipitate severe hypoglycemia.
• Co‑administration with high‑dose corticosteroids that increase glucose production, potentially leading to uncontrolled hyperglycemia.
• Use with potassium‑sparing diuretics in patients at risk for hyperkalemia.

Use with caution

• Beta‑blockers, which may mask symptoms of hypoglycemia.
• Loop diuretics, which can exacerbate electrolyte disturbances.
• Drugs that affect renal function, such as aminoglycosides, due to altered glucose clearance.
• Anesthetics that may influence glucose metabolism during surgery.